西藏药业: 西藏诺迪康药业股份有限公司第八届董事会第十次会议决议公告

Meeting Details - The eighth board meeting of Tibet Nodi Kang Pharmaceutical Co., Ltd. was held on August 14, 2025, in Chengdu, with all 9 directors present [1] - The meeting was conducted in accordance with the Company Law and the Articles of Association [1] Resolutions Passed - All resolutions were approved unanimously with 9 votes in favor, 0 against, and 0 abstentions [2] - The resolutions included the approval of the 2025 semi-annual report and the profit distribution plan [1][2] - Additional resolutions regarding the cancellation of the supervisory board and amendments to the Articles of Association were also passed [2] Upcoming Events - The first extraordinary general meeting of 2025 is scheduled, with details provided in a separate announcement [2]